Skip to main content
Year archive

Alkem Laboratories Limited — 2026 filings

All 110 regulatory filings released by Alkem Laboratories Limited (ALKEM) in 2026, sourced directly from the official regulator.

110 Filings
2026 Period
2026 filings (110)
Filing Released Lang
Please find enclosed herewith the details of the Analyst / Investor meeting to be held on 29th May,2026.
Regulatory Filings
2026-05-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-05-25 English
Please find attached herewith Intimation of Conference Call of Q4FY26 and FY26 Financial Result.
Regulatory Filings
2026-05-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-05-20 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve (i) The Standalone and Consolidated ...
Regulatory Filings
2026-05-19 English
General Updates
Board/Management Information
2026-05-18 English
Please find Attached herewith Intimation regarding Appointment of Senior Management Personnel.
Board/Management Information
2026-05-18 English
Press Release
Regulatory Filings
2026-05-08 English
This is to Inform you regarding US FDA inspection conducted today at the Company'' s CRO facility located at Taloja.
Regulatory Filings
2026-05-08 English
Please find Attached herewith Disclosure under Regulation 30 of SEBI(LODR) 2015.
Regulatory Filings
2026-05-05 English
Action(s) initiated or orders passed
Regulatory Filings
2026-05-05 English
Please find attached herewith Intimation about US FDA Inspection at Company'' s manufacturing facility located at Amaliya, Daman.
Regulatory Filings
2026-05-02 English
General Updates
Regulatory Filings
2026-05-02 English
Action(s) initiated or orders passed
Legal Proceedings Report
2026-04-24 English
Please find attached herewith intimation in respect of an order passed by Statutory Authority under the Income Tax Act, 1961
Regulatory Filings
2026-04-24 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-04-24 English
General Updates
Board/Management Information
2026-04-24 English
Please find attached herewith intimation for Change in Key Managerial Personnel - Resignation of Chief Executive Officer
Regulatory Filings
2026-04-24 English
Please find Attached herewith Intimation for Incorporation of Wholly owned subsidiary of the Company.
Regulatory Filings
2026-04-13 English
General Updates
Regulatory Filings
2026-04-13 English
Reply to Clarification- Financial results
Regulatory Filings
2026-04-10 English
Please find attached herewith Press release- Alkem Launches A to Z Daily, an everyday multivitamin supplement for body and mind.
Regulatory Filings
2026-04-07 English
Press Release
Regulatory Filings
2026-04-07 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-04-07 English
Please find attached herewith intimation about increase in investment to be made for setting up of manufacturing facility of the Company in Ujjain, Madhya Pradesh.
Regulatory Filings
2026-04-02 English
General Updates
Capital/Financing Update
2026-04-02 English
Please find attached herewith Intimation regarding change in Senior Management.
Regulatory Filings
2026-03-31 English
Cessation
Board/Management Information
2026-03-31 English
Please Find Attached herewith Intimation for Incorporation of Wholly Owned Subsidiary of the Company as a ''Scientific Office''.
Regulatory Filings
2026-03-30 English
General Updates
Capital/Financing Update
2026-03-30 English
This is to inform you that Mr. Samsher Kumar Deo has been appointed as Senior Management Position in the Company effective from 27th March,2026
Regulatory Filings
2026-03-27 English
Appointment
Board/Management Information
2026-03-27 English
Please find attached herewith Intimation regarding Closure of Trading Window.
Regulatory Filings
2026-03-27 English
Trading Window
Regulatory Filings
2026-03-27 English
Please find attached herewith Press release on Alkem launches Semaglutide injection in India, with weekly therapy starting at INR 450/-
Regulatory Filings
2026-03-21 English
Press Release
Capital/Financing Update
2026-03-21 English
Please find attached herewith Intimation regarding receipt of EU GMP Certificate for the Company manufacturing facility located at Daman, India.
Regulatory Filings
2026-03-20 English
Press Release
Regulatory Filings
2026-03-20 English
Please find enclosed herewith the details of the Analyst / Investor meeting to be held on 26th March,2026.
Regulatory Filings
2026-03-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-03-20 English
Updates
Capital/Financing Update
2026-03-18 English
Please find attached herewith intimation regarding allotment of land for setting up of a greenfield formulations manufacturing facility of the Company in Ujjain, Madhya Pradesh.
Regulatory Filings
2026-03-18 English
Please find attached herewith Intimation regarding receipt of EU GMP Certificate for the Company manufacturing facility located at Baddi, India.
Regulatory Filings
2026-03-14 English
General Updates
Regulatory Filings
2026-03-14 English
Please find attached herewith update on Acquisition.
Regulatory Filings
2026-03-06 English
General Updates
Capital/Financing Update
2026-03-06 English
Please find attached herewith Investor meet on Alkem MedTech''s strategic way forward- video Recording.
Regulatory Filings
2026-02-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-02-20 English
Please find attached herewith updated Investor meet Presentation on Alkem MedTech ''s strategic way forward.
Regulatory Filings
2026-02-18 English
Investor Presentation
Investor Presentation
2026-02-18 English
Please find attached herewith Schedule of Analyst/Investor Meetings.
Regulatory Filings
2026-02-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2026-02-17 English
Investor Presentation
Investor Presentation
2026-02-16 English
Enclosed please find herewith investor meet presentation on Alkem MedTech''s strategic way forward
Regulatory Filings
2026-02-16 English
Please find attached herewith Q3 FY26- Earnings Call Transcript.
Regulatory Filings
2026-02-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2026-02-16 English
General Updates
Regulatory Filings
2026-02-16 English
Enclosed please find updated disclosure with regards to closure of USFDA inspection at the manufacturing facility of Enzene Biosciences Limited, a subsidiary of the Company in India located ....
Regulatory Filings
2026-02-16 English
Copy of Newspaper Publication
Regulatory Filings
2026-02-14 English
Enclosed please find herewith newspaper publication.
Regulatory Filings
2026-02-14 English
General Updates
Regulatory Filings
2026-02-14 English
Enclosed please find herewith disclosure with regards to closure USFDA inspection at the manufacturing facility of Enzene Biosciences Limited, a subsidiary of the Company in India
Regulatory Filings
2026-02-14 English
Please find enclosed herewith the details of the Analyst / Investor meeting.
Regulatory Filings
2026-02-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
2026-02-13 English
Please find attached herewith Newspaper Publication informing the record date fixed Interim Dividend for 2025-2026.
Regulatory Filings
2026-02-13 English
Please find attached herewith Newspaper Publication informing the record date fixed Interim Dividend for 2025-2026.
Regulatory Filings
2026-02-13 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the '' Q3 & 9MFY26 Earnings Conference Call'' is ....
Regulatory Filings
2026-02-13 English
Copy of Newspaper Publication
Regulatory Filings
2026-02-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-02-13 English
Press Release
Capital/Financing Update
2026-02-13 English
Please find enclosed herewith Press Release.
Regulatory Filings
2026-02-13 English
Please find enclosed herewith the updated details of the Analyst / Institutional Investor meetings.
Regulatory Filings
2026-02-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2026-02-13 English
Trading Window
Regulatory Filings
2026-02-13 English
Investor Presentation
Interim / Quarterly Report
2026-02-13 English
General Updates
Capital/Financing Update
2026-02-13 English
Pl find enclosed press release and analyst presentation on Q3 & 9MFY26 earnings and business updates of the Company.
Regulatory Filings
2026-02-13 English
The Financial Results of the Company for the quarter and nine months ended 31st December, 2025 having been communicated to the Stock Exchanges today i.e. 13th February, 2026, the trading ....
Regulatory Filings
2026-02-13 English
General Updates
Regulatory Filings
2026-02-13 English
Amendment(s)
Regulatory Filings
2026-02-13 English
This is to inform you that M/s, Alkem Medtech Pvt Ltd , a wholly owned subsidiary of the Company in India has offered to acquire at least 51% and upto 55% of the issued share capital of ....
Regulatory Filings
2026-02-13 English
Amalgamation/Merger
M&A Activity
2026-02-13 English
Please find attached herewith an update on incorporation of JV in Saudi Arabia.
Regulatory Filings
2026-02-13 English
Dividend
Regulatory Filings
2026-02-13 English
In continuation of our letter dated 23rd Jan, 2026, the BOD at its meeting held today 13th Feb has declared interim dividend of Rs.43 per equity share on face value of Rs. 2 per share for Fy 25-26.
Regulatory Filings
2026-02-13 English
Record Date
Regulatory Filings
2026-02-13 English
This is to inform you that an Amendment cum Supplemental Agreement dated 13th February, 2026 has been entered into by the Company with Enzene, Eight Roads Ventures, F-Prime Capital and ....
Regulatory Filings
2026-02-13 English
Pls find enclosed unaudited financial results along with LRR for quarter and nine month ended 31st dec, 25
Regulatory Filings
2026-02-13 English
Outcome of Board Meeting
Regulatory Filings
2026-02-13 English
This is to inform you that the Board of Directors of the Company has at its meeting held on 13th February, 2026 approved the amalgamation of M/s. Adroit Biomed Limited, a wholly owned subsidiary ....
Regulatory Filings
2026-02-13 English
Dividend
Regulatory Filings
2026-02-13 English
Please find enclosed herewith the outcome of Board meeting dated 13th Feb, 2026.
Regulatory Filings
2026-02-13 English
Please find attached herewith revised intimation of Conference Call on Q3FY26 and 9MFY26 financial results - Change in Conference Call Timing.
Regulatory Filings
2026-02-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-02-12 English
Please Find Attached Herewith Intimation under Regulation 30 SEBI LODR 2015.
Regulatory Filings
2026-02-06 English
Amalgamation/Merger
Capital/Financing Update
2026-02-06 English
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q3 and 9MFY26 ....
Regulatory Filings
2026-01-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2026-01-23 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-23 English
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve (i) the Standalone and Consolidated ...
Regulatory Filings
2026-01-23 English
Board Meeting — Financial Results/Dividend
Capital/Financing Update
2026-01-23 English
Please find attached herewith disclosure in respect of order passed by the Statutory Authority.
Regulatory Filings
2026-01-22 English
Action(s) initiated or orders passed
Legal Proceedings Report
2026-01-22 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
Regulatory Filings
2026-01-17 English
Please find attached herewith disclosure in respect of order passed by Statutory Authority.
Regulatory Filings
2026-01-13 English
Action(s) initiated or orders passed
Regulatory Filings
2026-01-13 English
Please find attached herewith Press release on Alkem launches Renocia cyclical therapy, a nutritional supplements kit, to support hair growth.
Regulatory Filings
2026-01-08 English
Press Release
Capital/Financing Update
2026-01-08 English
Please find attached herewith disclosure in respect of order passed by the Statutory Authority.
Regulatory Filings
2026-01-01 English
Action(s) initiated or orders passed
Regulatory Filings
2026-01-01 English